Shin Jung-Hae, Kwon Hyuk-Woo, Cho Hyun-Jeong, Rhee Man Hee, Park Hwa-Jin
Department of Biomedical Laboratory Science, College of Biomedical Science and Engineering, Inje University, Inje-ro, Gimhae-si, Gyeongsangnam-do, Korea.
Department of Biomedical Laboratory Science, College of Medical Science, Konyang University, Gasuwon-dong, Seo-gu, Daejeon, Korea.
J Ginseng Res. 2015 Oct;39(4):354-64. doi: 10.1016/j.jgr.2015.03.006. Epub 2015 Mar 28.
Intracellular Ca(2+)([Ca(2+)]i) is a platelet aggregation-inducing molecule. Therefore, understanding the inhibitory mechanism of [Ca(2+)]i mobilization is very important to evaluate the antiplatelet effect of a substance. This study was carried out to understand the Ca(2+)-antagonistic effect of total saponin from Korean Red Ginseng (KRG-TS).
We investigated the Ca(2+)-antagonistic effect of KRG-TS on cyclic nucleotides-associated phosphorylation of inositol 1,4,5-trisphosphate receptor type I (IP3RI) and cyclic adenosine monophosphate (cAMP)-dependent protein kinase (PKA) in thrombin (0.05 U/mL)-stimulated human platelet aggregation.
The inhibition of [Ca(2+)]i mobilization by KRG-TS was increased by a PKA inhibitor (Rp-8-Br-cAMPS), which was more stronger than the inhibition by a cyclic guanosine monophosphate (cGMP)-dependent protein kinase (PKG) inhibitor (Rp-8-Br-cGMPS). In addition, Rp-8-Br-cAMPS inhibited phosphorylation of PKA catalytic subunit (PKAc) (Thr(197)) by KRG-TS. The phosphorylation of IP3RI (Ser(1756)) by KRG-TS was very strongly inhibited by Rp-8-Br-cAMPS compared with that by Rp-8-Br-cGMPS. These results suggest that the inhibitory effect of [Ca(2+)]i mobilization by KRG-TS is more strongly dependent on a cAMP/PKA pathway than a cGMP/PKG pathway. KRG-TS also inhibited the release of adenosine triphosphate and serotonin. In addition, only G-Rg3 of protopanaxadiol in KRG-TS inhibited thrombin-induced platelet aggregation.
These results strongly indicate that KRG-TS is a potent beneficial compound that inhibits [Ca(2+)]i mobilization in thrombin-platelet interactions, which may result in the prevention of platelet aggregation-mediated thrombotic disease.
细胞内钙离子([Ca²⁺]i)是一种诱导血小板聚集的分子。因此,了解[Ca²⁺]i动员的抑制机制对于评估一种物质的抗血小板作用非常重要。本研究旨在了解高丽红参总皂苷(KRG - TS)的钙拮抗作用。
我们研究了KRG - TS对凝血酶(0.05 U/mL)刺激的人血小板聚集中与环核苷酸相关的I型肌醇1,4,5 - 三磷酸受体(IP3RI)磷酸化和环磷酸腺苷(cAMP)依赖性蛋白激酶(PKA)的钙拮抗作用。
PKA抑制剂(Rp - 8 - Br - cAMPS)增强了KRG - TS对[Ca²⁺]i动员的抑制作用,其抑制作用比环磷酸鸟苷(cGMP)依赖性蛋白激酶(PKG)抑制剂(Rp - 8 - Br - cGMPS)更强。此外,Rp - 8 - Br - cAMPS抑制了KRG - TS对PKA催化亚基(PKAc)(苏氨酸¹⁹⁷)的磷酸化。与Rp - 8 - Br - cGMPS相比,Rp - 8 - Br - cAMPS对KRG - TS引起的IP3RI(丝氨酸¹⁷⁵⁶)磷酸化有非常强的抑制作用。这些结果表明,KRG - TS对[Ca²⁺]i动员的抑制作用更强烈地依赖于cAMP/PKA途径而非cGMP/PKG途径。KRG - TS还抑制了三磷酸腺苷和5 - 羟色胺的释放。此外,KRG - TS中仅原人参二醇型的G - Rg3抑制凝血酶诱导的血小板聚集。
这些结果有力地表明,KRG - TS是一种有效的有益化合物,可抑制凝血酶 - 血小板相互作用中的[Ca²⁺]i动员,这可能导致预防血小板聚集介导的血栓性疾病。